Picco, Vincent

Research Associate

Centre Scientifique de Monaco, Principality of Monaco

Targeted therapies

We study the capacity of certain anti-angiogenic targeted therapies to permeabilize and pass the BBB.

Existing collaborations relevant to drug delivery

J. Gavard Centre de Recherche en Cancérologie Immunologie Nantes-Angers CRCINA, CNRS ERL 6001, INSERM U1232 Université de Nantes

Publications relevant to drug delivery

Pagnuzzi-Boncompagni M, Picco V,  Vial V, Planas-Bielsa V,  Vandenberghe A,  Grépin R, Durivault J, Montemagno C, Martial S, Doyen J, Gavard J, Pagès G. The anti-angiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma. doi: https://doi.org/10.1101/2020.09.18.301028

  Email for contact details